Potential neurological treatments often advance to clinical trials on shaky evidence, study says
Clinical trials of drug treatments for neurological diseases such as Alzheimer's and Parkinson's often fail because the animal studies that preceded them were poorly designed or biased in their interpretation, according to ...
Jul 16, 2013
0
0